Erk activation as a possible mechanism of transformation of subependymal nodule into subependymal giant cell astrocytoma

Folia Neuropathologica

Volumn 53, Issue 1, 2015, Pages 8-14

  Siedlecka, Monika ^a   Szlufik, Stanislaw ^a   Grajkowska, Wieslawa ^b,c   Roszkowski, Marcin ^c   Jóźwiak, Jaroslaw ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^c CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

Author keywords

Erk; Subependymal giant cell astrocytoma; Subependymal nodule; Tuberous sclerosis

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROTEIN KINASE B;

ARTICLE; BRAIN TUMOR; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN TISSUE; NEUROPATHOLOGY; PROTEIN PHOSPHORYLATION; SUBEPENDYMAL GIANT CELL ASTROCYTOMA; SUBEPENDYMAL NODULE; TUBEROUS SCLEROSIS; UPREGULATION; WESTERN BLOTTING; ASTROCYTOMA; CELL TRANSFORMATION; ENZYMOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ASTROCYTOMA; BRAIN NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; ENZYME ACTIVATION; HUMANS; MAP KINASE SIGNALING SYSTEM; TUBEROUS SCLEROSIS;

EID: 84925781846     PISSN: 16414640     EISSN: 1509572X     Source Type: Journal    
DOI: 10.5114/fn.2015.49969     Document Type: Article

References (17)

1. Buccoliero AM, Franchi A, Castiglione F, Gheri C F, Mussa F, Giordano F, Gentori L, Taddei GL. Subependymal giant cell astrocytoma (SEGA): Is it an astrocytoma? Morphological, immunohistochemical and ultrastructural study. Neuropathology 2009;29:25-30.
2. Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex. N Engl J Med 2006;355:1345-1356.
3. Grajkowska W, Kotulska K, Jurkiewicz E, Roszkowski M, Daszkiewicz P, Jóźwiak S, Matyja E. Subependymal giant cell astrocytomas with atypical histological features mimicking malignant gliomas. Folia Neuropathol 2011;49:39-46.
4. Gyure KA, Prayson RA. Subependymal giant cell astrocytoma: a clinicopathologic study with HMB45 and MIB-1 immunohistochemical analysis. Mod Pathol 1997;10:313-317.
5. Han S, Santos TM, Puga A, Roy J, Thiele EA, McCollin M, Stemmer-Rachamimov A, Ramesh V. Phosphorylation of tuberin as a novel mechanism for somatic inactivation of the tuberous sclerosis complex proteins in brain lesions. Cancer Res 2004;64:812-816.
6. Jozwiak J, Grajkowska W, Kotulska K, Jozwiak S, Zalewski W, Zajączkowska A, Roszkowski M, Slupianek A, Wlodarski P. Brain tumor formation in tuberous sclerosis depends on Erk activation. Neuromolecular Med 2007;9:117-127.
7. Jozwiak J, Jozwiak S, Wlodarski P. Possible mechanisms of disease development in tuberous sclerosis. Lancet Oncol 2008;9:73-79.
8. Jóźwiak J, Sontowska I, Bikowska B, Grajkowska W, Galus R, Roszkowski M. Favourable prognosis in medulloblastoma with extensive nodularity is associated with mitogen-activated protein kinase upregulation. Folia Neuropathol 2011;49:257-261.
9. Kalantari BN, Salamon N. Neuroimaging of tuberous sclerosis: spectrum of pathologic findings and frontiers in imaging. Am J Roentgenol 2008;190:W304-W309.
10. Mizuguchi M, Takashima S. Neuropathology of tuberous sclerosis. Brain Dev 2001;23:508-515.
11. Northrup H, Krueger DA; International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol 2013;49:243-254.
12. Osborne J P, Fryer A, Webb D. Epidemiology of tuberous sclerosis. Ann N Y Acad Sci 1991;615:125-127.
13. Rak B, Szlufik S, Grajkowska W, Perek D, Dembowska-Bagińska B, Filipek I, Daszkiewicz P, Wlodarski P, Jóźwiak J. Upregulation of mitogen-activated protein kinase in ganglioglioma. Folia Neuropathol 2013;51:283-289.
14. Roach ES, Gomez MR, Northrup H. Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol 1998;13:624-628.
15. Roth J, Roach ES, Bartels U, Jóźwiak S, Koenig MK, Weiner HL, Franz DN, Wang HZ. Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012. Pediatr Neurol 2013;49:439-444.
16. Rovira A, Ruiz-Falco ML, Garcia-Esparza E, Lopez-Laso E, Macaya A, Malaga I, Vazquez E, Vincente J. Recommendations for the radiological diagnosis and follow-up of neuropathological abnormalities associated with tuberous sclerosis complex. J Neurooncol 2014;118:205-223.
17. Wlodarski P, Grajkowska W, Łojek M, Rainko K, Jóźwiak J. Activation of Akt and Erk pathways in medulloblastoma. Folia Neuropathol 2006;44:214-220.